4/A
Changes in Ownership
Amneal Pharmaceuticals, Inc. Filed Acc 0001628280-26-021746
Options or other derivatives
- Co-CEO acquired 544,663 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Patel Chintu Co-CEO | 2026-03-02 | Grant or award · Performance-Based Restricted Stock Units | +544,663 | 544,663 | D | ||
Loading xslF345X06/wk-form4a_1774642844.xml…